The original rise of Sildenafil presented a significant opportunity for investors , but its patent has lapsed , creating a challenging landscape. Generic versions have flooded the space , diminishing profits and putting pressure on profit margins . While established pharmaceutical companies continue a presence in this field , the outlook looks u… Read More